What factors hinder the effectiveness of immunotherapies for cancer treatment ... studying similar markers for memory formation in human T cells, this effect was not as clear.

After two infusions, the tumor markers in her blood declined by more ... such as BRCA mutations for breast and ovarian cancer, the problem that had famously spurred Angelina Jolie to undergo ...

Background: Renal cell carcinoma ... tumor-specific markers, especially single-cell RNA sequencing (scRNA-seq). Methods: We performed an exploratory study on three pathological types of RCC with a ...

renal cell cancer, ovarian cancer, bladder cancer, head and neck cancer, and gastric cancer. While single agent CTLA-4 or PD-1 pathway blockade has demonstrated clear anti-tumor activity across ...

Researchers have looked at the ratio of some types of white blood cells to predict prognosis with early stage tumors, but thus far it does not have a clear ... stage lung cancer. Paraneoplastic ...

It's a little pill with big responsibilities. But despite its primary role to prevent pregnancy, the contraceptive pill (the ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy have developed ...